Search Results
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Bekaii-Saab on the Response Rate of Pembrolizumab in MSI-H CRC
Dr. Bekaii-Saab on Tolerability of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC
Dr. Bekaii-Saab on the ReDOS Study in Metastatic Colorectal Cancer
Dr. Tanios Bekaii-Saab on Having the Institute for Value-Based Medicine
Tanios Bekaii-Saab, MD: Mutations in Colorectal Cancer
1L FOLFOXIRI plus cetuximab or bevacizumab for RAS wild-type mCRC
Dr. O'Neil Discusses Napabucasin With FOLFIRI and Bevacizumab in CRC
BEACON CRC: first-line bevacizumab in colorectal cancer treatment
Upfront Bevacizumab and Cetuximab Compared in Metastatic Colorectal Cancer
Dr. Saab on a Phase II Study of the Oncolytic Virus Reolysin for Pancreatic Cancer
